- Home
- MIST vs CATO Comparison
MIST vs CATO Comparison
Compare MIST & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- CATO
- Stock Information
- Founded
- MIST 2003
- CATO 1946
- Country
- MIST Canada
- CATO United States
- Employees
- MIST N/A
- CATO N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- MIST Health Care
- CATO Consumer Discretionary
- Exchange
- MIST Nasdaq
- CATO Nasdaq
- Market Cap
- MIST 89.8M
- CATO 59.2M
- IPO Year
- MIST N/A
- CATO N/A
- Fundamental
- Price
- MIST $1.92
- CATO $2.78
- Analyst Decision
- MIST Strong Buy
- CATO
- Analyst Count
- MIST 2
- CATO 0
- Target Price
- MIST $7.50
- CATO N/A
- AVG Volume (30 Days)
- MIST 613.1K
- CATO 40.6K
- Earning Date
- MIST 08-07-2025
- CATO 08-21-2025
- Dividend Yield
- MIST N/A
- CATO 6.07%
- EPS Growth
- MIST N/A
- CATO N/A
- EPS
- MIST N/A
- CATO N/A
- Revenue
- MIST N/A
- CATO $642,949,000.00
- Revenue This Year
- MIST N/A
- CATO N/A
- Revenue Next Year
- MIST N/A
- CATO N/A
- P/E Ratio
- MIST N/A
- CATO N/A
- Revenue Growth
- MIST N/A
- CATO N/A
- 52 Week Low
- MIST $0.63
- CATO $2.19
- 52 Week High
- MIST $2.75
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- MIST 67.01
- CATO 48.86
- Support Level
- MIST $1.85
- CATO $2.65
- Resistance Level
- MIST $2.02
- CATO $2.99
- Average True Range (ATR)
- MIST 0.09
- CATO 0.25
- MACD
- MIST 0.01
- CATO -0.02
- Stochastic Oscillator
- MIST 73.75
- CATO 27.47
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.